Sanofi

Aventisub LLC

Kumar Amith

Khullar Praveen

Prasad Kum

Prajapati Dilip

Kumar Ramesh

Madavan Bindu

The present invention relates to a liquid pharmaceutical composition for oral administration comprising fexofenadine and/or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable carrier which is either polyethylene glycol or a propylene glycol-based solvent, or a mixture thereof, from 35 to 90% wt. of a pharmaceutical excipient stabilizing fexofenadine and/or a pharmaceutically acceptable salt thereof, said pharmaceutical excipient consisting of glycerol with optionally sorbitol. The invention also relates to the uses of these compositions as a medicament and to the process for preparing said compositions.

Liquid pharmaceutical composition for oral administration comprising fexofenadine

The present invention relates to a monolayer tablet for use in the treatment of tuberculosis comprising a mixture of: &#x2014;granules comprising isoniazid, pyrazinamide, ethambutol or a pharmaceutically acceptable salt thereof and at least one granulation binder, &#x2014;rifampicin in powder form, &#x2014;extragranular excipients, wherein all of the granules have a particle size that is less than 0.599 mm, preferably less than 0.5 mm, more preferably less than 0.422 mm, and to its process of preparation.

Antitubercular composition comprising rifampicin, isoniazid, ethambutol and pyrazinamide and its process of preparation

Growing community of inventors

Gurdaspur, India

Kumar Amith